Idoya Lahortiga

Title: Idoya Lahortiga: Innovator in Biotechnological Solutions for T-Cell Acute Lymphoblastic Leukemia

Introduction

Idoya Lahortiga is a prominent inventor based in Leuven, Belgium. She has made significant contributions to the field of biotechnology, particularly in the diagnosis and treatment of T-cell acute lymphoblastic leukemia. Her innovative work has the potential to improve patient outcomes in this challenging area of medicine.

Latest Patents

Idoya holds a patent for her invention titled "Diagnosis and treatment of T-cell acute lymphoblastic leukemia." This invention focuses on biotechnological methods to diagnose or treat this specific type of leukemia. The patent details methods for diagnosing the disease by determining the presence of a duplication of the MYB gene in patient cells. Additionally, it includes the development of inhibitors that can neutralize the biological activity of MYB, either alone or in combination with inhibitors targeting NOTCH1, to treat T-cell acute lymphoblastic leukemia.

Career Highlights

Throughout her career, Idoya has worked with notable organizations, including Vib Vzw and Katholieke Universiteit Leuven. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Idoya has collaborated with esteemed colleagues such as Peter Marynen and Jan Cools. These partnerships have further enhanced her research and innovation in the biotechnology sector.

Conclusion

Idoya Lahortiga is a trailblazer in the field of biotechnology, with her patent addressing critical needs in the diagnosis and treatment of T-cell acute lymphoblastic leukemia. Her work exemplifies the impact of innovative thinking in advancing medical science and improving patient care.